Close Menu

NEW YORK (GenomeWeb) – Great Basin Scientific's board has approved a 1-for-300 reverse stock split, following approval by its shareholders, the company said on Thursday in a document filed with the US Securities and Exchange Commission.

The shareholder approval took place during a special meeting, during which shareholders approved a reverse stock split at a ratio of between 1 for 200 and 1 for 300. Subsequently, the board approved the split at the 1-for-300 ratio.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.